All Stories

  1. Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death

    Article • OncoImmunology, May 2017, Taylor & Francis

    Dr. Bryan E. Strauss

  2. Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy

    Article • Cancer Biology & Therapy, September 2016, Taylor & Francis

    Dr. Bryan E. Strauss

  3. AAVPG: A vigilant vector where transgene expression is induced by p53

    Article • Virology, December 2013, Elsevier

    Dr. Bryan E. Strauss